Coverage
-
October 14, 2016
Pfizer Inc. has reached a settlement with AntiCancer Inc. to resolve claims the drug giant unlawfully terminated a patent licensing agreement for AntiCancer's research technology following Pfizer's 2009 merger with fellow pharmaceutical behemoth Wyeth.
1 other articles on this case.
View all »